These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32648057)

  • 1. Optimal Timing of VT Ablation for Patients with ICD Therapies.
    Radinovic A; Baratto F; Della Bella P
    Curr Cardiol Rep; 2020 Jul; 22(9):91. PubMed ID: 32648057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials.
    Lima da Silva G; Nunes-Ferreira A; Cortez-Dias N; de Sousa J; J Pinto F; Caldeira D
    J Interv Card Electrophysiol; 2020 Dec; 59(3):603-616. PubMed ID: 32948937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Tung R; Xue Y; Chen M; Jiang C; Shatz DY; Besser SA; Hu H; Chung FP; Nakahara S; Kim YH; Satomi K; Shen L; Liang E; Liao H; Gu K; Jiang R; Jiang J; Hori Y; Choi JI; Ueda A; Komatsu Y; Kazawa S; Soejima K; Chen SA; Nogami A; Yao Y;
    Circulation; 2022 Jun; 145(25):1839-1849. PubMed ID: 35507499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.
    Patel D; Hasselblad V; Jackson KP; Pokorney SD; Daubert JP; Al-Khatib SM
    J Interv Card Electrophysiol; 2016 Mar; 45(2):111-7. PubMed ID: 26695501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.
    Atti V; Vuddanda V; Turagam MK; Vemula P; Shah Z; Nagam H; Yandrapalli S; Jazayeri MA; Koerber S; Gonzalez JV; Natale A; Di Biase L; Lakkireddy DR
    J Interv Card Electrophysiol; 2018 Nov; 53(2):207-215. PubMed ID: 29680972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
    Santangeli P; Muser D; Maeda S; Filtz A; Zado ES; Frankel DS; Dixit S; Epstein AE; Callans DJ; Marchlinski FE
    Heart Rhythm; 2016 Jul; 13(7):1552-9. PubMed ID: 26961297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis.
    Liu G; Xu X; Yi Q; Lv T
    J Interv Card Electrophysiol; 2021 Sep; 61(3):435-443. PubMed ID: 33723693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized controlled trials.
    Prasitlumkum N; Navaravong L; Desai A; Desai D; Cheungpasitporn W; Rattanawong P; Bunch TJ; Jongnarangsin K; Chokesuwattanaskul R
    Heart Rhythm; 2022 Dec; 19(12):2054-2061. PubMed ID: 35820619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    Arenal Á; Ávila P; Jiménez-Candil J; Tercedor L; Calvo D; Arribas F; Fernández-Portales J; Merino JL; Hernández-Madrid A; Fernández-Avilés FJ; Berruezo A
    J Am Coll Cardiol; 2022 Apr; 79(15):1441-1453. PubMed ID: 35422240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease.
    Martinez BK; Baker WL; Konopka A; Giannelli D; Coleman CI; Kluger J; Cronin EM
    Heart Rhythm; 2020 Jan; 17(1):e206-e219. PubMed ID: 31082362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiofrequency ablation in ventricular tachycardia: an alternative to implanted cardioverter defibrillator?].
    Noble S; Shah D
    Rev Med Suisse; 2006 May; 2(67):1406, 1408-11. PubMed ID: 16786957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium.
    Kahle AK; Jungen C; Alken FA; Scherschel K; Willems S; Pürerfellner H; Chen S; Eckardt L; Meyer C
    Europace; 2022 Apr; 24(4):538-551. PubMed ID: 34967892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for catheter ablation of ventricular tachycardia].
    Deneke T; Israel CW; Krug J; Nentwich K; Müller P; Mügge A; Schade A
    Dtsch Med Wochenschr; 2013 Sep; 138(39):1952-6. PubMed ID: 24046136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation for ventricular tachycardia in ischaemic heart disease; acute success and long-term outcome.
    Mørk TJ; Kristensen J; Gerdes JC; Jensen HK; Lukac P; Nielsen JC
    Scand Cardiovasc J; 2014 Feb; 48(1):27-34. PubMed ID: 24460505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.